Bio-Rad Laboratories Inc.Class A share price logo

Bio-Rad Laboratories Inc.Class A

NASDAQ: BIO

Mid Cap

$300.79

+2.50

(+0.84%)

as on

Bio-Rad Laboratories Inc.Class A Stock Performance

as on June 27, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $293.48
    $305.00
    downward going graph

    2.43%

    Downside

    1.40%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $236.73
    $343.12
    downward going graph

    21.30%

    Downside

    14.07%

    Upside

    downward going graph

Bio-Rad Laboratories Inc.Class A share price movements today

Previous Close
$298.29
Open
$302.95
Volume
208.7K
Day's Low - High
$293.48 - $305.00
52 Week Low - High
$236.73 - $343.12

Bio-Rad Laboratories Inc.Class A Historical Returns

1 Month Return
+ 0.47 %
3 Month Return
+ 7.87 %
1 Year Return
+ 22.52 %
3 Year Return
-18.4 %
5 Year Return
-52.92 %

Bio-Rad Laboratories Inc.Class A Stock Fundamentals & Key Indicators

Check Bio-Rad Laboratories Inc.Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.5B

EPS (TTM)

9.0024

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.83%

PE Ratio (TTM)

46.52

Industry PE ratio

12.055454545454545

PEG Ratio

1.1905

EBITDA

444.8M

Revenue (TTM)

2.6B

Profit Margin

6.52%

Return On Equity TTM

2.50%

Bio-Rad Laboratories Inc.Class A Stock Valuation

Track how Bio-Rad Laboratories Inc.Class A P/E has moved over time to understand its valuation trends.

Bio-Rad Laboratories Inc.Class A in the last 5 years

  • Overview

  • Trends

Lowest (23.50x)

June 30, 2025

Industry (12.06x)

June 26, 2026

Today (46.52x)

June 26, 2026

Highest (47.76x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 46.52x

Bio-Rad Laboratories Inc.Class A vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bio-Rad Laboratories Inc.Class A with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$7.5B-52.92%46.526.52%NA
BUY$120.3B20.19%36.3513.21%1.11%
BUY$51.6B-13.37%46.9417.39%NA
BUY$102.6B-35.55%21.4813.20%3.52%
BUY$157.6B-17.28%25.3513.90%2.7%

Stock Returns calculator for Bio-Rad Laboratories Inc.Class A Stock including INR - Dollar returns

The Bio-Rad Laboratories Inc.Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio-Rad Laboratories Inc.Class A investment value today

Current value as on today

₹1,36,036

Returns

₹36,036

(+36.04%)

Returns from Bio-Rad Laboratories Inc.Class A Stock

₹23,543 (+23.54%)

Dollar Impact

₹12,493 (+12.49%)

Analyst Recommendation on Bio-Rad Laboratories Inc.Class A Stock

Based on 10 analysts

BUY

60.00%

Buy

40.00%

Hold

0.00%

Sell

Based on 10 analysts, 60% of analysts recommend a 'BUY' rating for Bio-Rad Laboratories Inc.Class A. Average target price of $297

Bio-Rad Laboratories Inc.Class A Share Price Target

Get share price movements and forecasts by analysts on Bio-Rad Laboratories Inc.Class A.

What analysts predicted

-1.28%DOWNSIDE

Target Price

$297

Current Price

$300.79

Analyzed by

10 Analysts

Target

$297.00

Bio-Rad Laboratories Inc.Class A target price $297, a slight downside of -1.28% compared to current price of $300.79. According to 10 analysts rating.

Indian Investors' Interest in Bio-Rad Laboratories Inc.Class A Stock

Search interest for Bio-Rad Laboratories Inc.Class A Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Bio-Rad Laboratories Inc.Class A Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
681
610
638
649
667
585
651
653
693
592
Gross Profit
365
326
355
355
341
306
345
343
345
309
Operating Income
97
52
101
64
58
23
77
66
61
34
EBITDA
493
551
-2,727
922
-847
133
477
-364
993
-636
Interest Expense
12
12
12
12
12
12
12
12
12
12
Depreciation
37
37
36
38
39
38
40
44
42
40
Income Before Tax
428
491
-2,786
861
-908
83
414
-431
929
-689
Income Tax Expense
78
107
-620
208
-193
19
96
-89
209
-162
Net Income
349
383
-2,165
653
-715
64
317
-341
720
-527
Net Profit Margin
51.34%
62.85%
-339.16%
100.53%
-107.24%
10.93%
48.77%
-52.36%
103.87%
-89.02%

Bio-Rad Laboratories Inc.Class A Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2,068
2,160
2,290
2,311
2,545
2,922
2,802
2,671
2,566
2,583
Gross Profit
1,138
1,187
1,224
1,256
1,437
1,638
1,567
1,426
1,378
1,343
Operating Income
53
116
-108
229
421
500
482
337
269
270
EBITDA
206
269
674
2,458
5,078
5,588
-4,488
-654
-2,142
1,249
Interest Expense
23
23
23
23
21
1
38
49
48
49
Depreciation
-
148
138
134
138
133
137
144
151
165
Income Before Tax
41
97
507
2,261
4,918
5,449
-4,704
-850
-2,342
995
Income Tax Expense
13
-16
146
502
1,103
1,194
-1,076
-212
-498
235
Net Income
28
114
360
1,758
3,814
4,254
-3,627
-637
-1,844
759
Net Profit Margin
1.36%
5.31%
15.76%
76.08%
149.83%
145.57%
-129.45%
-23.86%
-71.86%
29.42%

Bio-Rad Laboratories Inc.Class A Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
383
-2,165
653
-715
64
-120
-341
720
-11
Operating Cash Flow
69
97
163
124
129
116
120
164
108
Investing Cash Flow
-43
-30
-55
-30
2
-115
-43
-34
-93
Financing Cash Flow
0
-96
-95
-26
-97
-136
-52
3
-44
Change in Cash
29
-26
4
77
33
-151
26
131
-23

Bio-Rad Laboratories Inc.Class A Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
122
365
1,758
3,814
4,245
-3,627
-637
-1,844
759
Operating Cash Flow
104
285
457
584
656
194
374
455
532
Investing Cash Flow
-175
-186
-208
-69
-784
-1,207
20
-160
-189
Financing Cash Flow
0
-48
-22
-523
-55
973
-425
-218
-283
Change in Cash
-72
49
228
4
-195
-36
-30
85
40

Global Institutional Holdings in Bio-Rad Laboratories Inc.Class A

Funds
Holdings
Fuller & Thaler Asset Management Inc
1.94%
BlackRock Inc
6.28%
Massachusetts Financial Services Company
1.48%
Dimensional Fund Advisors, Inc.
4.07%
Bank of America Corp
1.66%

Insights on Bio-Rad Laboratories Inc.Class A

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BIO stock has moved up by 6.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Stryker Corporation has given 0.7% return, outperforming this stock by 18.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 693.2M → 592.1M (in $), with an average decrease of 14.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 720.0M → -527.1M (in $), with an average decrease of 173.2% per quarter

About Bio-Rad Laboratories Inc.Class A

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
OrganisationBio-Rad Laboratories Inc.Class A
Headquarters1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
IndustryMedical Devices
CEOMr. Norman D. Schwartz
E-voting on sharesClick here to vote

Key Management of Bio-Rad Laboratories Inc.Class A

Name

Title

Mr. Ruben Argueta

Vice President of Investor Relations

Ms. Courtney C. Enloe

Executive VP, General Counsel & Secretary

Mr. Roop K. Lakkaraju CPA

Executive VP & CFO

Mr. James J. Barry

Executive VP & President of Life Science Group

Mr. Rajat Mehta

Executive Vice President of Global Commercial Operations

Ms. Nanditha R. Yelamanchi

Executive Vice President of Global Human Resources

Mr. Michael Crowley

Executive Vice President of Global Commercial Operations

Mr. Norman D. Schwartz

Chairman & CEO

Mr. Jonathan P. DiVincenzo

President & COO

Matthew Werner

Senior VP and Chief Compliance & Privacy Officer

FAQs

What is Bio-Rad Laboratories Inc.Class A share price today?

Bio-Rad Laboratories Inc.Class A share price today is $300.79 as on at the close of the market. Bio-Rad Laboratories Inc.Class A share today touched a day high of $305 and a low of $293.48.

What is the 52 week high and 52 week low for Bio-Rad Laboratories Inc.Class A share?

Bio-Rad Laboratories Inc.Class A share touched a 52 week high of $343.12 on and a 52 week low of $236.73 on . Bio-Rad Laboratories Inc.Class A stock price today i.e. is closed at $300.79,which is 12.34% down from its 52 week high and 27.06% up from its 52 week low.

What is Bio-Rad Laboratories Inc.Class A's market capitalisation today?

Bio-Rad Laboratories Inc.Class A market capitalisation is $0.01T as on .

How to invest in Bio-Rad Laboratories Inc.Class A Stock (BIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bio-Rad Laboratories Inc.Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bio-Rad Laboratories Inc.Class A Shares that will get you 0.0050 shares as per Bio-Rad Laboratories Inc.Class A share price of $300.79 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Bio-Rad Laboratories Inc.Class A Stock (BIO) from India?

Indian investors can start investing in Bio-Rad Laboratories Inc.Class A (BIO) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Bio-Rad Laboratories Inc.Class A stock (as per the Rupee-Dollar exchange rate as on ). Based on Bio-Rad Laboratories Inc.Class A share’s latest price of $300.79 as on June 27, 2026 at 8:45 am IST, you will get 0.0332 shares of Bio-Rad Laboratories Inc.Class A. Learn more about fractional shares .

What are the returns that Bio-Rad Laboratories Inc.Class A has given to Indian investors in the last 5 years?

Bio-Rad Laboratories Inc.Class A stock has given -52.92% share price returns and 27.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?